AMERICAN HEART ASSOCIATION Embargoed until 12:10 p.m. CT/1:10 p.m. ET, Friday, Nov. 13, 2020 DALLAS, Nov. 13, 2020 — A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented...
Month: <span>November 2020</span>
Post
New COVID-19 vaccine must be kept ultra-cold; will require novel distribution network
The cold, hard fact is: Pfizer blazed a trail in creating a touted COVID-19 vaccine, but now it must help to equally pioneer an unprecedented way to distribute the drug across the United States and the globe, says a supply chain expert at Washington University in St. Louis. Delivering this breakthrough vaccine at steeply refrigerated...
Post
Type 2 diabetes: Drug duo may remain effective for 2 years
A trial suggests that in patients who are no longer responding to metformin, taking a combination of two newer drugs is safe and yields clinical benefits for at least 2 years. Insulin helps regulate the amount of glucose circulating in the blood. In type 2 diabetes, the body does not produce enough insulin, its cells no longer...
Post
FDA approves prescription-only Apple Watch app for PTSD nightmares
By Rich Haridy, November 10, 2020 A new prescription-only system uses an Apple Watch to detect and disrupt nightmares through gentle vibrations without waking the user NightWare The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of...
Post
Five important questions about Pfizer’s COVID-19 vaccine
Reviewed by Emily Henderson, B.Sc.Nov 11 2020 Pfizer’s announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were released. There was certainly something to crow...
Post
Study finds lasting fatigue common after COVID-19 infection
PLOS More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues. Fatigue is one of the most common initial presenting complaints of people...
Post
National study reveals new insights into avoidable harm in primary care
NIHR GREATER MANCHESTER PATIENT SAFETY TRANSLATIONAL RESEARCH CENTRE A national study* of general practices in England has revealed the frequency of incidents of significant avoidable harm in primary care, and also important new details. For example, according to the research the main causes are diagnostic error (more than 60%), medication incidents (more than 25%) and delayed referrals...
Post
A molecule from gut bacteria reduces effect of diabetes medication
by Margareta G. Kubista, University of Gothenburg The action of metformin, the classic drug used to treat diabetes by stabilizing blood sugar, can be blocked by a molecule from the bacteria in our intestines, a University of Gothenburg study shows. Metformin is the primary treatment option for type 2 diabetes, but there are major variations in...
Post
The EAR-PC study findings encourages screening for hearing loss in older adults
AMERICAN ACADEMY OF FAMILY PHYSICIANS Hearing loss is the second most common disability in the United States and comes with it a higher risk for being diagnosed with significant health conditions, such as hypertension, diabetes, dementia and depression, as well as higher health care cost and use. The Early Auditory Referral-Primary Care (EAR-PC) study was...
Post
Gene signature predicts whether localized prostate cancer is likely to spread
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER NEW YORK, NY (Nov. 10, 2020)–Researchers have identified a genetic signature in localized prostate cancer that can predict whether the cancer is likely to spread, or metastasize, early in the course of the disease and whether it will respond to anti-androgen therapy, a common treatment for advanced disease. The new...